Table 2 Univariable and multi-variable Cox regression analysis for DFS.
Univariable analysis | Multi-variable analysis | |||
|---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | |
Age, yearsa | 1.00 (0.99–1.02) | 0.775 | ||
BMI, kg/m2 | ||||
18.5–23.0 | Ref. b | Ref. | ||
<18.5 | 0.76 (0.24–2.45) | 0.644 | 0.50 (0.12–2.06) | 0.334 |
≥23.0 | 1.57 (1.09–2.26) | 0.016 | 1.98 (1.34–2.92) | 0.001 |
WBC count, ×103/uLa | 0.99 (0.89–1.09) | 0.764 | ||
ALC, ×103/uLa | 0.52 (0.37–0.74) | <0.001 | 0.43 (0.29–0.65) | <0.001 |
ANC, ×103/uLa | 1.06 (0.96–1.17) | 0.270 | ||
NLR, ×103/uLa | 1.09 (1.04–1.14) | 0.001 | 1.01 (0.94–1.07) | 0.881 |
Platelet count, ×103/uLa | 1.00 (0.99–1.00) | 0.785 | ||
Monocyte count, ×103/uLa | 1.72 (0.38–7.80) | 0.484 | ||
Histologic grade | ||||
Low | Ref. | Ref. | ||
Intermediate | 1.51 (0.89–2.55) | 0.128 | 0.94 (0.54–1.65) | 0.831 |
High | 2.03 (1.18–3.50) | 0.011 | 0.85 (0.44–1.65) | 0.625 |
Nuclear grade | ||||
Low | Ref. | |||
Intermediate | 1.29 (0.64–2.60) | 0.486 | ||
High | 1.94 (0.96–3.91) | 0.065 | ||
Oestrogen receptor | ||||
Negative | Ref. | Ref. | ||
Positive | 0.54 (0.38–0.78) | 0.001 | 0.82 (0.46–1.49) | 0.516 |
Progesterone receptor | ||||
Negative | Ref. | Ref. | ||
Positive | 0.54 (0.38–0.76) | <0.001 | 0.89 (0.50–1.56) | 0.678 |
HER2 | ||||
Negative | Ref. | Ref. | ||
Positive | 1.59 (1.10–2.31) | 0.015 | 1.19 (0.80–1.79) | 0.388 |
Ki-67 LI, % | ||||
<14 | Ref. | Ref. | ||
≥14 | 2.40 (1.67–3.45) | <0.001 | 1.94 (1.22–3.07) | 0.005 |
Tumour size, mm | ||||
≤20 | Ref. | Ref. | ||
>20 | 2.12 (1.50–3.01) | <0.001 | 1.47 (1.00–2.18) | 0.050 |
Positive lymph node, count | ||||
0 | Ref. | Ref. | ||
1–3 | 1.16 (0.77–1.76) | 0.471 | 1.00 (0.65–1.55) | 0.992 |
≥4 | 2.17 (1.27–3.73) | 0.005 | 1.30 (0.72–2.34) | 0.385 |